Leadership Training & Women of SpyGlass! Watching the team at SpyGlass Pharma, Inc. cultivate friendships, grow professionally, and support one another has been an incredible experience.

Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...

Mankind Pharma, India’s fourth largest drugmaker by domestic sales, is setting its sights on anti-obesity drugs like Semaglutide, better known by brand names Ozempic and Wegovy, which goes off ...

(Image/Freepik) Donald Trump’s election victory was welcomed by many in India and especially by the Indian pharmaceutical industry. They saw in his return as the US president, elements that ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand ...

The meeting is expected to cover topics including Medicare drug price negotiations, the role of pharmacy benefit managers, and tariffs on pharmaceutical products, according to an industry source ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the next four years ahead of a planned meeting with the president on Thursday.

Its time for Indian pharma companies to look beyond the U.S. market as the Trump administration has threatened to impose 25% tariff on pharmaceutical imports. This move would disrupt India’s ...

Commenting on the results, Bhushan Akshikar, MD of GlaxoSmithKline Pharmaceuticals, highlighted the company’s strategic initiatives in strengthening its market presence and enhancing access to ...

Kennedy Jr. — who also happens to now run the Department of Health and Human Services — have castigated the pharma sector for its all-too-cozy relationship with the FDA, including its penchant ...